HIGHLIGHTS
- who: Jia-Rui Zheng and colleagues from the Capital Medical University, China have published the Article: Hepatitis B functional cure and immune response, in the Journal: (JOURNAL)
- how: The effects of TLR8 agonist GS-9688 on immune cell subsets were studied in_vitro using PBMC from CHB patients and healthy participants in_vitro and the results showed that GS-9688 could increase the frequency of CD4+ Tfh cells activated NK cells mucosal associated variant T_cells and HBV specific CD8+T_cells as well as reduce t hat of CD4+ regulatory T_cells and MDSCs . The results indicated that DF . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.